PMID- 20335053 OWN - NLM STAT- MEDLINE DCOM- 20100831 LR - 20100521 IS - 1095-8320 (Electronic) IS - 1045-1056 (Linking) VI - 38 IP - 3 DP - 2010 May TI - Extraneous agents testing for substrates of avian origin and viral vaccines for poultry: current provisions and proposals for future approaches. PG - 362-5 LID - 10.1016/j.biologicals.2010.01.010 [doi] AB - In the 1970s the European Pharmacopoeia (Ph. Eur.) established the first requirements for testing starting materials for vaccines and the vaccines themselves. These requirements also cover testing for freedom from extraneous agents of specific pathogen free (SPF) chicken flocks, the embryonated eggs derived from them and viral vaccines for poultry. This was the first common European approach initiated by the Ph. Eur. as an institution of the Council of Europe and it was the beginning of building a scientific basis for vaccine quality. In the following years, the increasingly detailed requirements concerning viral purity also impacted viral vaccines for poultry, SPF chicken flocks and the embryonated eggs derived from them. The core of these requirements is formed by the list of extraneous agents that must be tested for and the accepted test methods. In the early 1990s and in 2004, the next steps were taken towards the harmonization of quality regulations for the production and testing of veterinary immunological products, this time at the level of the European Community. With the first step, good manufacturing practices (GMP) and good laboratory practices (GLP) were introduced, ensuring more consistent production, validation of production procedures and testing. The next step introduced the risk assessment, which covers the evaluation of the quality of production and control. The intention of these efforts is to contribute to the quality, safety and purity of the products placed on the market. It makes sense that, based on the outcome of the risk-evaluation, a reduction of in-process and final product testing may be called for in certain cases. However, despite the fact that the quality of the starting materials and vaccines has been increased over the years, the provisions of the Ph. Eur. have not been adjusted. Progress made by the manufacturers of starting materials and vaccines with respect to increasing the quality of their products should be recognised. This review gives an analysis of the current provisions of the Ph. Eur. and makes some proposals on how the requirements concerning the testing of extraneous agents could be modified to take into consideration the increase in quality that has been achieved over the past few decades. CI - 2010 The International Association for Biologicals. Published by Elsevier Ltd. All rights reserved. FAU - Jungback, Carmen AU - Jungback C AD - Paul-Ehrlich-Institut, Langen, Germany. junca@pei.de FAU - Motitschke, Andreas AU - Motitschke A LA - eng PT - Journal Article PT - Review DEP - 20100323 PL - England TA - Biologicals JT - Biologicals : journal of the International Association of Biological Standardization JID - 9004494 RN - 0 (Viral Vaccines) SB - IM MH - Animals MH - Chick Embryo MH - Chickens MH - Drug Contamination/*prevention & control MH - Europe MH - Guidelines as Topic MH - Pharmacopoeias as Topic MH - Quality Control MH - Specific Pathogen-Free Organisms MH - Viral Vaccines/*analysis/immunology/*standards RF - 14 EDAT- 2010/03/26 06:00 MHDA- 2010/09/02 06:00 CRDT- 2010/03/26 06:00 PHST- 2010/01/25 00:00 [received] PHST- 2010/01/25 00:00 [accepted] PHST- 2010/03/26 06:00 [entrez] PHST- 2010/03/26 06:00 [pubmed] PHST- 2010/09/02 06:00 [medline] AID - S1045-1056(10)00037-0 [pii] AID - 10.1016/j.biologicals.2010.01.010 [doi] PST - ppublish SO - Biologicals. 2010 May;38(3):362-5. doi: 10.1016/j.biologicals.2010.01.010. Epub 2010 Mar 23.